在安大略省 (2000-2017) 基于人口的队列研究中,肝硬化患者的因果特定死亡率
Peter L Wang1, Maya Djerboua2, Jennifer A Flemming1,2,3
1Departments of Medicine, Kingston, Ontario, Canada.
Hepatology communications
|June 28, 2023
概括
在补偿性肝硬化患者中,心血管疾病和癌症导致的死亡人数多于肝病. 这凸显了对肝硬化患者的综合性死亡风险评估的需要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 肝硬化患者面临高死亡风险,但当代特定原因死亡数据很少.
- 了解这些原因对于改善患者治疗结果和医疗保健策略至关重要.
研究的目的:
- 调查和报告一个大型的,当代的肝硬化患者队列中因特定原因的死亡模式.
- 分析不同肝硬化病因,疾病补偿状况和人口因素的死亡原因.
主要方法:
- 一项回顾性队列研究利用了加拿大安大略省 (2000-2017年) 的行政卫生数据.
- 识别了患有肝硬化的成年患者,对病因进行分类 (HCV,HBV,ALD,NAFLD,自身免疫/其他).
- 随访患者以死亡率,肝移植或研究结束为目的,分析原因,包括肝脏相关,心血管,非肝脏恶性瘤和外部原因.
主要成果:
- 这项研究包括202,022名肝硬化患者 (52%的NAFLD,26%的ALD,11%的HCV).
- 在5年的中位数中,发生了81,428例死亡;肝移植率很低 (<5%).
- 在补偿性肝硬化中,非肝癌 (30%) 和心血管疾病 (27%) 是导致死亡的主要原因,特别是在NAFLD患者中.
结论:
- 心血管疾病和与癌症相关的死亡率超过了补偿性肝硬化患者的肝脏相关死亡率.
- 与肝脏相关的死亡率在病毒性肝炎和酒精相关的肝病中最高,以及在去补偿性肝硬化或肝细胞癌 (HCC) 患者中最高.
- 这些发现强调了在肝硬化护理中管理非肝脏相关并发症的重要性.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
17.2K
相关概念视频
01:20Actuarial Approach
99
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
99
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
01:24Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
01:26Diseases of the Liver and Gallbladder
674
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
674
01:20Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
01:22Life Tables
135
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
135